Table 2.

Comparison of the frequency of traditional CVRFs in men and women depending on the degree of inflammation at the time of disease diagnosis

	N	Frequency of CVRF at the time of diagnosis			N	Frequency of CVRF at the time of enrolment
		Normal APR at diagnosis, n (%)	Increased APR at diagnosis, n (%)	P value		Normal APR at diagnosis, n (%)	Increased APR at diagnosis, n (%)	P value
Hypertension
Men	57	25 (15)	32 (23)	0.066	90	34 (19)	56 (37)	<0.001*
Women	28	8 (10)	20 (21)	0.060	39	11 (14)	28 (28)	0.026*
Dyslipidaemia
Men	80	35 (20)	45 (31)	0.033*	115	53 (30)	62 (41)	0.042*
Women	36	12 (16)	24 (24)	0.16	52	19 (24)	33 (33)	0.21
Obesity
Men	22	13 (8)	9 (7)	0.64	90	34 (19)	56 (37)	0.047*
Women	21	8 (11)	13 (15)	0.50	39	11 (14)	28 (28)	0.032*
Diabetes mellitus
Men	4	4 (2)	0 (0)	0.13	24	14 (8)	10 (7)	0.61
Women	5	1 (1)	4 (4)	0.31	11	1 (1)	10 (10)	0.024*

Normal APR: CRP <3 mg/L and ESR <15 mm/first hour at diagnosis.

Increased APR: CRP >3 mg/L and/or ESR ≥15 mm/first hour at diagnosis.

Values in bold meant that the differences were statistically significant

*P<0.05.

APR, acute phase reactant; CRP, C reactive protein; CVRF, cardiovascular risk factor; ESR, erythrocyte sedimentation rate.